This heterogeneity is primarily attributed to mutations in von Hippel-Lindau (VHL), which result in the constitutive activation of hypoxia-inducible factors in ccRCC cells [11]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.